XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Earnings (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
Net sales $ 1,673 $ 1,686 $ 3,102 $ 3,448
Cost of products sold 951 948 1,784 1,903
Gross profit 722 738 1,318 1,545
Selling and administrative expenses 262 280 539 561
Advertising costs 190 191 356 392
Research and development costs 29 31 57 62
Loss on divestiture 0 0 0 118
Interest expense 25 22 48 43
Other (income) expense, net 1 (23) (4) (45)
Earnings before income taxes 215 237 322 414
Income tax expense 54 43 79 117
Net earnings 161 194 243 297
Less: Net earnings attributable to noncontrolling interests 4 1 6 5
Net earnings attributable to Clorox $ 157 $ 193 $ 237 $ 292
Net earnings per share attributable to Clorox        
Basic net earnings per share (in dollars per share) $ 1.29 $ 1.55 $ 1.94 $ 2.36
Diluted net earnings per share (in dollars per share) $ 1.29 $ 1.54 $ 1.93 $ 2.34
Weighted average shares outstanding (in thousands)        
Basic (in shares) 121,602 123,766 122,116 123,781
Diluted (in shares) 121,915 124,662 122,466 124,669